Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Epitel logo — Revolutionizing how brain health is monitored.

Epitel

Revolutionizing how brain health is monitored.

Founded 2014 United States Salt Lake City, United States 41 employees Series A Total: $20.40M Digital Health, Health Care +1

General Information

Company Name Epitel
Founded Year 2014
Location United States Salt Lake City, United States
Employees 41
Industries Digital Health, Health Care, Medical Devices
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Epitel. To contact Epitel, visit epitel.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Epitel compare?

A PDF of Epitel and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Epitel soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Epitel

Epitel is a Health Care startup that aims to revolutionize how brain health is monitored. Founded in 2017, the company is headquartered in the United States. Epitel is empowering clinicians, patients, and caregivers who live with and care for neurological disorders through wearables and powerful AI.

The latest milestone for Epitel was the $12.50M Series A investment on 16 February 2022. The investors in this round included Catalyst Health Ventures, Genoa Ventures, Dexcom Ventures, MedMountain Ventures, OSF Healthcare, Wavemaker 360, and SLC Angels.

This significant investment reflects the confidence of prominent venture capital firms in the potential of Epitel's innovative approach to neurological disorder monitoring. With this latest injection of funds, Epitel is well-positioned to further develop and market their wearable devices and AI technologies, making a real impact in the healthcare industry.

Business keywords: brain health, neurological disorders, wearables, remote monitoring, clinician empowerment

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $12.50M 7
Genoa Ventures Dexcom Ventures MedMountain Ventures
Genoa Ventures, Dexcom Ventures +5
16 Feb 2022
Venture Round $100.00K 1
Ideaship
Ideaship
29 Oct 2019
Grant $2.80M 1
National Institutes of Health
20 Aug 2016
Grant $5.00M 1
National Institutes of Health
01 Jul 2014

Epitel Alternatives & Competitors

View All Alternatives
Epitel vs
CenSyn, Inc.
CenSyn, Inc. United States

Instant insight, one mind at a time.

Grant
6 employees
Health Care, Medical Devices
Compare Epitel vs CenSyn, Inc.
Epitel vs
Neuroelectrics
Neuroelectrics Spain

Reinventing brain health. Personalized technologies for brain monitoring and stimulation.

Series A
66 employees
AI, Biotechnology
Compare Epitel vs Neuroelectrics
Epitel vs
JuneBrain Inc.
JuneBrain Inc. United States

Empowering eye care and neurology communities through remote monitoring of disease.

Non Equity Assistance
13 employees
Biotechnology, Health Care
View all alternatives

FAQ About Epitel

Revolutionizing how brain health is monitored.
Epitel was founded in 2014.
Epitel is headquartered in Salt Lake City, United States.
Epitel operates in Digital Health, Health Care and Medical Devices. Its work centres on brain health, neurological disorders, wearables and remote monitoring.
Epitel has approximately 41 employees.
Epitel has completed 4 funding rounds, raising a total of $20.40M. The latest funding stage is Series A.
Top alternatives and competitors to Epitel include CenSyn, Inc., Neuroelectrics, JuneBrain Inc., McGovern Institute for Brain Research, NeuroVigil, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Epitel and CenSyn, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Epitel, https://bouncewatch.com/company/epitel, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes